Veterinary Biological Vaccines Market Size, Share, Growth, and Industry Analysis, By Types (Live Attenuated Vaccines,Inactivated Vaccines,Others) , Applications (Livestock,Swine,Chicken,Others) and Regional Insights and Forecast to 2033

Detailed TOC of Global Veterinary Biological Vaccines Market Research Report 2025

1 Veterinary Biological Vaccines Market Overview
1.1 Product Definition
1.2 Veterinary Biological Vaccines by Type
1.2.1 Global Veterinary Biological Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Biological Vaccines by Application
1.3.1 Global Veterinary Biological Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Others
1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biological Vaccines Revenue 2020-2031
1.4.2 Global Veterinary Biological Vaccines Sales 2020-2031
1.4.3 Global Veterinary Biological Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Biological Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Biological Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Biological Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biological Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Biological Vaccines, Date of Enter into This Industry
2.8 Global Veterinary Biological Vaccines Market Competitive Situation and Trends
2.8.1 Global Veterinary Biological Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
2.8.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Biological Vaccines Market Scenario by Region
3.1 Global Veterinary Biological Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Biological Vaccines Sales by Region: 2020-2031
3.2.1 Global Veterinary Biological Vaccines Sales by Region: 2020-2025
3.2.2 Global Veterinary Biological Vaccines Sales by Region: 2026-2031
3.3 Global Veterinary Biological Vaccines Revenue by Region: 2020-2031
3.3.1 Global Veterinary Biological Vaccines Revenue by Region: 2020-2025
3.3.2 Global Veterinary Biological Vaccines Revenue by Region: 2026-2031
3.4 North America Veterinary Biological Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Biological Vaccines Sales by Country (2020-2031)
3.4.3 North America Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Biological Vaccines Sales by Country (2020-2031)
3.5.3 Europe Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Biological Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Biological Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Biological Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Biological Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biological Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Biological Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Biological Vaccines Sales by Type (2020-2031)
4.1.1 Global Veterinary Biological Vaccines Sales by Type (2020-2025)
4.1.2 Global Veterinary Biological Vaccines Sales by Type (2026-2031)
4.1.3 Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Biological Vaccines Revenue by Type (2020-2031)
4.2.1 Global Veterinary Biological Vaccines Revenue by Type (2020-2025)
4.2.2 Global Veterinary Biological Vaccines Revenue by Type (2026-2031)
4.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Biological Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Biological Vaccines Sales by Application (2020-2031)
5.1.1 Global Veterinary Biological Vaccines Sales by Application (2020-2025)
5.1.2 Global Veterinary Biological Vaccines Sales by Application (2026-2031)
5.1.3 Global Veterinary Biological Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Biological Vaccines Revenue by Application (2020-2031)
5.2.1 Global Veterinary Biological Vaccines Revenue by Application (2020-2025)
5.2.2 Global Veterinary Biological Vaccines Revenue by Application (2026-2031)
5.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Biological Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Company Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Company Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Yebio
6.7.1 Yebio Company Information
6.7.2 Yebio Description and Business Overview
6.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yebio Veterinary Biological Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 DHN
6.8.1 DHN Company Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 WINSUN
6.9.1 WINSUN Company Information
6.9.2 WINSUN Description and Business Overview
6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
6.9.5 WINSUN Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Company Information
6.11.2 Virbac Description and Business Overview
6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Company Information
6.12.2 CAVAC Description and Business Overview
6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Company Information
6.13.2 Kyoto Biken Laboratories Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Company Information
6.14.2 FATRO Description and Business Overview
6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Vaksindo
6.15.1 Vaksindo Company Information
6.15.2 Vaksindo Description and Business Overview
6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
6.15.5 Vaksindo Recent Developments/Updates
6.16 Bio-Labs
6.16.1 Bio-Labs Company Information
6.16.2 Bio-Labs Description and Business Overview
6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
6.16.5 Bio-Labs Recent Developments/Updates
6.17 Avimex Animal Health
6.17.1 Avimex Animal Health Company Information
6.17.2 Avimex Animal Health Description and Business Overview
6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
6.17.5 Avimex Animal Health Recent Developments/Updates
6.18 MEVAC
6.18.1 MEVAC Company Information
6.18.2 MEVAC Description and Business Overview
6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
6.18.5 MEVAC Recent Developments/Updates
6.19 Biovac
6.19.1 Biovac Company Information
6.19.2 Biovac Description and Business Overview
6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
6.19.5 Biovac Recent Developments/Updates
6.20 Atafen
6.20.1 Atafen Company Information
6.20.2 Atafen Description and Business Overview
6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
6.20.5 Atafen Recent Developments/Updates
6.21 Dyntec
6.21.1 Dyntec Company Information
6.21.2 Dyntec Description and Business Overview
6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
6.21.5 Dyntec Recent Developments/Updates
6.22 Ringpu Biology
6.22.1 Ringpu Biology Company Information
6.22.2 Ringpu Biology Description and Business Overview
6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
6.22.5 Ringpu Biology Recent Developments/Updates
6.23 Jinyu Bio-technology
6.23.1 Jinyu Bio-technology Company Information
6.23.2 Jinyu Bio-technology Description and Business Overview
6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
6.23.5 Jinyu Bio-technology Recent Developments/Updates
6.24 Jinhe Biotechnology
6.24.1 Jinhe Biotechnology Company Information
6.24.2 Jinhe Biotechnology Description and Business Overview
6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
6.24.5 Jinhe Biotechnology Recent Developments/Updates
6.25 China Animal Husbandry Industry
6.25.1 China Animal Husbandry Industry Company Information
6.25.2 China Animal Husbandry Industry Description and Business Overview
6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
6.25.5 China Animal Husbandry Industry Recent Developments/Updates
6.26 Wuhan Keqian Biology
6.26.1 Wuhan Keqian Biology Company Information
6.26.2 Wuhan Keqian Biology Description and Business Overview
6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
6.26.5 Wuhan Keqian Biology Recent Developments/Updates
6.27 Pulike Biological Engineering
6.27.1 Pulike Biological Engineering Company Information
6.27.2 Pulike Biological Engineering Description and Business Overview
6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
6.27.5 Pulike Biological Engineering Recent Developments/Updates
6.28 Chengdu Kanghua Biological Products
6.28.1 Chengdu Kanghua Biological Products Company Information
6.28.2 Chengdu Kanghua Biological Products Description and Business Overview
6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Biological Vaccines Industry Chain Analysis
7.2 Veterinary Biological Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biological Vaccines Production Mode & Process Analysis
7.4 Veterinary Biological Vaccines Sales and Marketing
7.4.1 Veterinary Biological Vaccines Sales Channels
7.4.2 Veterinary Biological Vaccines Distributors
7.5 Veterinary Biological Vaccines Customer Analysis
8 Veterinary Biological Vaccines Market Dynamics
8.1 Veterinary Biological Vaccines Industry Trends
8.2 Veterinary Biological Vaccines Market Drivers
8.3 Veterinary Biological Vaccines Market Challenges
8.4 Veterinary Biological Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer